You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Lung Cancer, Small Cell

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

NSCLC, Carcinoma, Small Cell Lung, Carcinoma, Thymic Trial run by the National Cancer Institute (NCI) (AZD6244, MK-2206,

Active, not recruiting
  • Carcinoma, Non-Small-Cell Lung
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Aug 24, 2022

Lung Cancer, Nonsmall Cell, Lung Cancer, Lung Cancer, Small Cell Trial in United States (NanoPac (sterile nanoparticulate

Active, not recruiting
  • Lung Cancer, Nonsmall Cell
  • +3 more
  • NanoPac (sterile nanoparticulate paclitaxel) Powder for Suspension
  • Gainesville, Florida
  • +3 more
Jan 9, 2023

Double-dose Furmonertinib in Treatment of Slow

Not yet recruiting
  • Non Small Cell Lung Cancer
  • +3 more
  • (no location specified)
Oct 31, 2023

Extensive Stage Small Cell Lung Cancer (ES-SCLC) Trial (HS-20093)

Not yet recruiting
  • Extensive Stage Small Cell Lung Cancer (ES-SCLC)
  • (no location specified)
Sep 19, 2023

NSCLC, EGFR Gene Mutation, EGFR-TKI Resistant Mutation Trial (Nintedanib, gefitinib, erlotinib, afatinib)

Not yet recruiting
  • Non-small Cell Lung Cancer
  • +2 more
  • Nintedanib, gefitinib, erlotinib, afatinib
  • (no location specified)
Oct 2, 2023

NSCLC Trial in Shanghai

Not yet recruiting
  • Non-small Cell Lung Cancer
    • Shanghai, Shanghai, China
      Shanghai Pulmonary Hospital
    Jul 20, 2023

    Specific Protein Overexpression in Adult Non-Small Cell Lung

    Not yet recruiting
    • Non Small Cell Lung Cancer
      • (no location specified)
      Sep 29, 2023

      Stage II-IIIB(N2) NSCLC Trial in Shanghai (TQB2450, Carboplatin, Pemetrexed)

      Not yet recruiting
      • Stage II-IIIB(N2) Non-small Cell Lung Cancer
      • Shanghai, Shanghai, China
        Shanghai Pulmonary Hospital
      Oct 26, 2023

      Small Cell Lung Cancer Trial (Tarlatamab)

      Available
      • Small Cell Lung Cancer
      • (no location specified)
      Sep 26, 2023

      NSCLC, Neoadjuvant Therapy, Radiotherapy Trial in Yangzhou (drug, radiation, other)

      Recruiting
      • Non-small Cell Lung Cancer
      • +3 more
      • Yangzhou, Jiangsu, China
        People's hospital of northern jiangsu
      Sep 26, 2023

      Limited Stage Lung Small Cell Carcinoma, Stage I Lung Cancer, Stage II Lung Cancer Trial in Nashville (drug, biological,

      Not yet recruiting
      • Limited Stage Lung Small Cell Carcinoma
      • +3 more
      • Nashville, Tennessee
        Vanderbilt University/Ingram Cancer Center
      Nov 10, 2023

      Extensive Stage Small Cell Lung Cancer Trial (hSTC810 400 mg + Paclitaxel, hSTC810 800 mg + Paclitaxel)

      Not yet recruiting
      • Extensive Stage Small Cell Lung Cancer
      • hSTC810 400 mg + Paclitaxel
      • hSTC810 800 mg + Paclitaxel
      • (no location specified)
      Aug 24, 2023

      Relapsed Small Cell Lung Cancer Trial in Beijing (Irinotecan HCl liposome Injection, Topotecan)

      Not yet recruiting
      • Relapsed Small Cell Lung Cancer
      • Irinotecan hydrochloride liposome Injection
      • Topotecan
      • Beijing, China
        Cancer Hospital, Chinese Academy of Medical Sciences
      Nov 7, 2023

      Lung Cancer, Lung Cancer, Small Cell Trial in Gaziantep (Pulmonary Rehabilitation)

      Not yet recruiting
      • Lung Cancer
      • Lung Cancer, Small Cell
      • Pulmonary Rehabilitation
      • Gaziantep, Turkey
        Hasan Kalyoncu Univercity
      Apr 1, 2022

      Small Cell Lung Cancer Trial in Cleveland (Alisertib)

      Not yet recruiting
      • Small Cell Lung Cancer
      • Cleveland, Ohio
        Cleveland Clinic
      Oct 18, 2023

      Rapid Autopsy Protocol for Patients With Small Cell Lung Cancer

      Recruiting
      • Small Cell Lung Cancer
      • Biospecimen Collection
      • Indianapolis, Indiana
      • +1 more
      Jun 2, 2023

      Extensive Stage Small Cell Lung Cancer

      Not yet recruiting
      • Extensive-stage Small-cell Lung Cancer
        • Changsha, Hunan, China
          Hunan Cancer hospital
        Aug 6, 2023

        TRAcking Non-small Cell Lung Cancer Evolution Through Therapy

        Not yet recruiting
        • Lung Cancer, Non-small Cell
        • Small Cell Lung Cancer
          • (no location specified)
          Nov 16, 2022

          Small Cell Lung Cancer, Neuroendocrine Carcinoma Trial in Zhengzhou (ZG006)

          Not yet recruiting
          • Small Cell Lung Cancer
          • Neuroendocrine Carcinoma
          • ZG006
          • Zhengzhou, Henan, China
            Henan Cancer Hospital
          Aug 6, 2023

          NSCLC Trial (Tirelizumab;Chemotherapy monotherapy)

          Not yet recruiting
          • Non-small Cell Lung Cancer
          • Tirelizumab；Chemotherapy monotherapy
          • (no location specified)
          Jul 27, 2023

          Identify Resected Non-small-cell Lung Cancer With High Risk of

          Recruiting
          • Non-small Cell Lung Cancer Stage IIIA
          • Resected non small cell lung cancer
          • Toulouse, France
            Julien MAZIERES
          Feb 8, 2023

          Metastatic Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 Trial in

          Not yet recruiting
          • Metastatic Lung Non-Small Cell Carcinoma
          • +2 more
          • Cetuximab
          • +2 more
          • Sacramento, California
            University of California Davis Comprehensive Cancer Center
          Oct 2, 2023

          NSCLC Trial (BGB-A445, Docetaxel, Tislelizumab)

          Not yet recruiting
          • Non-Small Cell Lung Cancer
          • (no location specified)
          Sep 6, 2023

          Non Small Cell Lung Cancer, NSCLC, Lung Cancer Trial in Port Saint Lucie, Greenville (BL-B01D1)

          Recruiting
          • Non Small Cell Lung Cancer
          • +2 more
          • Port Saint Lucie, Florida
          • +1 more
          Aug 11, 2023

          NSCLC Trial in Iowa City (Durvalumab, Pharmacological ascorbate, Surgery (SOC))

          Not yet recruiting
          • Non-small Cell Lung Cancer
          • Iowa City, Iowa
            University of Iowa
          Oct 10, 2023